These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17106141)

  • 21. Very late stent thrombosis after discontinuation of clopidogrel therapy.
    Conroy MM; Bolsin SN
    Med J Aust; 2009 Feb; 190(3):163. PubMed ID: 19203321
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
    Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged dual antiplatelet therapy improves clinical outcomes in high-risk patients implanted with sirolimus-eluting stents.
    Dean J; Yujie Z; Yingxin Z; Yuyang L; Yonghe G; Wanjun C; Zheng C
    Clin Cardiol; 2009 Mar; 32(3):164-8. PubMed ID: 19301293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study.
    Byrne RA; Schulz S; Mehilli J; Iijima R; Massberg S; Neumann FJ; ten Berg JM; Schömig A; Kastrati A;
    Am Heart J; 2009 Apr; 157(4):620-4.e2. PubMed ID: 19332187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case report of simultaneous thrombosis of two coronary artery stents in association with clopidogrel resistance.
    Lee JS; Dunn SP; Marshall HM; Cohen MG; Smyth SS
    Clin Cardiol; 2007 Apr; 30(4):200-3. PubMed ID: 17443655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Confined late stent thrombosis following clopidogrel withdrawal in a patient with multi-segment sirolimus-eluting stent implants.
    Zavalloni D; Belli G; Rossi M; Presbitero P
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):544-6. PubMed ID: 17568291
    [No Abstract]   [Full Text] [Related]  

  • 29. Late thrombosis of a drug-eluting stent overlapped in the in-stent restenotic lesion of a bare metal stent.
    Takeda S; Shirasawa K; Hatakeyama Y; Sasaki Y; Inenaga K; Takeoka R; Doi T; Hwang MW; Kawai C
    Int J Cardiol; 2007 Mar; 116(1):e25-6. PubMed ID: 17107727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization.
    Cola C; Brugaletta S; Martín Yuste V; Campos B; Angiolillo DJ; Sabaté M
    Vasc Health Risk Manag; 2009; 5(1):101-19. PubMed ID: 19436654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).
    Didier R; Morice MC; Barragan P; Noryani AAL; Noor HA; Majwal T; Hovasse T; Castellant P; Schneeberger M; Maillard L; Bressolette E; Wojcik J; Delarche N; Blanchard D; Jouve B; Ormezzano O; Paganelli F; Levy G; Sainsous J; Carrie D; Furber A; Berlan J; Darremont O; Le Breton H; Lyuycx-Bore A; Gommeaux A; Cassat C; Kermarrec A; Cazaux P; Druelles P; Dauphin R; Armengaud J; Dupouy P; Champagnac D; Ohlmann P; Ben Amer H; Kiss RG; Ungi I; Gilard M
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1202-1210. PubMed ID: 28641840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dual platelet aggregation inhibition in coronary artery stent implantation--what is evidence-based?].
    Baer FM; Erdmann E
    Dtsch Med Wochenschr; 2007 Jun; 132(23):1275-80. PubMed ID: 17541871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry.
    Orford JL; Lennon R; Melby S; Fasseas P; Bell MR; Rihal CS; Holmes DR; Berger PB
    J Am Coll Cardiol; 2002 Nov; 40(9):1567-72. PubMed ID: 12427407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
    Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous late stent thrombosis in two coronary arteries following drug-eluting stent implantation.
    Prasad SB; Malaiapan Y; Ahmar W; Meredith IT
    Cardiovasc Revasc Med; 2009; 10(3):188-90. PubMed ID: 19595402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very late paclitaxel-eluting stent thrombosis despite 21 months of clopidogrel treatment after percutaneous coronary intervention.
    Sardella G; Bucciarelli-Ducci C; Mancone M; Colantonio R; Sangiorgi GM; Fedele F
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):625-8. PubMed ID: 17667035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.
    Carlsson J; von Wagenheim B; Linder R; Anwari TM; Qvist J; Petersson I; Magounakis T; Lagerqvist B
    Clin Res Cardiol; 2007 Feb; 96(2):86-93. PubMed ID: 17180577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Severe myocardial infarction due to late and very late stent thrombosis after coronary artery stenting with drug-eluting stents].
    Krausgrill B; Erdmann E; Flesch M
    Dtsch Med Wochenschr; 2008 Oct; 133(40):2014-7. PubMed ID: 18819044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery.
    Jang SW; Kim DB; Kwon BJ; Shin D; Her SH; Park CS; Park HJ; Park MW; Cho EJ; Rho TH; Kim JH
    Int J Cardiol; 2010 Apr; 140(1):e8-11. PubMed ID: 19117624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.